Jefferies lowered the firm’s price target on Colgate-Palmolive (CL) to $85 from $86 and keeps a Hold rating on the shares. Comps get easier, retail inventory levels are in a better place, and valuation has pulled back, but Colgate still has some idiosyncratic risks that keeps the firm on the sidelines for now, the analyst tells investors in a research note. The firm noted that consumer perception of oral care has declined this year, and has not yet inflected positively in terms of value, willingness to participate, or favorability.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- The Week That Was, The Week Ahead: Macro & Markets, Dec. 14
- Colgate-Palmolive downgraded to Hold from Buy at Argus
- Colgate-Palmolive cut to Hold at Argus amid falling margins and volume pressure
- Midday Fly By: Nvidia can ship H200s to China, Campbell’s reports Q1 beat
- Synopsys upgraded, Warner Bros. downgraded: Wall Street’s top analyst calls
